On February 7, 2024, Harford, P.C. filed a lawsuit in the U.S. District Court for the Northern District of New York against CooperSurgical, Inc., a Connecticut based global medical device company that manufactures medical products for women’s fertility. The basis of the lawsuit alleges that CooperSurgical’s culture media product destroys embryos being stored prior to transfer to the women’s uterus.
In this case, Harford, P.C.’s clients reside in Suffolk County, New York and utilized a lab in Syracuse, New York for in vitro fertilization (“IVF”). The clinic successfully retrieved seven eggs and five were fertilized and placed in CooperSurgical’s defective cultural media for their critical stages of development.
Unfortunately, exposure to CooperSurgical’s defective culture media degraded all of the embryos, rendering them unviable, and all five embryos were lost.
Eventually, CooperSurgical issued a recall of its global media, specifically LGGG Lots 231020-018741, 231020-018742, and 231020-018743. The recall notice stated that CooperSurgical had received an alarming “sudden increase” in the number of complaints about these particular lots of media. According to CooperSurgical, these lots did not contain the required amount of magnesium necessary to nurture the development of healthy embryos in the medium.
Harford, P.C. is anticipating numerous additional filings against CooperSurgical for its defective culture media. If you or someone you know has been affected the CooperSurgical recall, please call Scott Harford at (212) 390-8983 or e-mail at scott.harford@harford-law.com.
We are here to help you.
